Results 41 to 50 of about 12,098 (189)
Objective To construct the recombinant plasmid carrying CD74-ROS1 fusion gene, and explore its effect on migration ability of A549 cells. Methods CD74 and ROS1 genes were obtained through PCR. The CD74-ROS1 fusion gene was constructed by fusion PCR.
WU Yazhou, LI Jia, ZHANG Lei
doaj +1 more source
Clonal and microclonal mutational heterogeneity in high hyperdiploid acute lymphoblastic leukemia. [PDF]
High hyperdiploidy (HD), the most common cytogenetic subtype of B-cell acute lymphoblastic leukemia (B-ALL), is largely curable but significant treatment-related morbidity warrants investigating the biology and identifying novel drug targets.
de Smith, Adam J +10 more
core +1 more source
Potential novel therapy targets in neuroendocrine carcinomas of the breast [PDF]
Neuroendocrine carcinoma (NEC) of the breast is a rare, special type of breast cancer, reportedly constituting 2% to 5% of all breast cancers. Although breast NEC does not have a specific targeted therapy, several new targeted therapies based on specific
Contreras, Elma +7 more
core +2 more sources
Prevalence of ROS1 fusion in Chinese patients with non‐small cell lung cancer
Background The study was conducted to investigate the clinicopathological features and prevalence of ROS1 gene fusion in Chinese patients with non‐small cell lung cancer (NSCLC).
Qing Zhang +15 more
doaj +1 more source
The DNA Repair Protein XRCC1 Functions in the Plant DNA Demethylation Pathway by Stimulating Cytosine Methylation (5-meC) Excision, Gap Tailoring, and DNA Ligation [PDF]
Background: Active DNA demethylation in plants is initiated by 5-meC DNA glycosylases of the ROS1/DME family and continued through a base excision repair pathway.
Córdoba-Cañero, Dolores +3 more
core +1 more source
Background ROS1 rearrangements are validated drivers in lung cancer, which have been identified in a small subset (1–2%) of patients with non-small cell lung cancer (NSCLC). To date, 18 fusion genes of ROS1 have been identified in NSCLC.
Shuguang Xu +6 more
doaj +1 more source
A novel CD74-ROS1 gene fusion in a patient with inflammatory breast cancer: a case report
Background CD74-ROS1 fusion genes have been detected in non-small cell lung carcinomas (NSCLC), but not in inflammatory breast cancer. Case presentation Herein, we report a CD74-ROS1 fusion gene identified in a 64-year-old Chinese woman with inflammatory
Huiyu Hu +5 more
doaj +1 more source
BackgroundThe clinical significance of majority oncogenic novel fusions is still unknown due to scarcity. Reciprocal ROS1 translocation is a rare form of ROS1 fusion and has not yet been clearly analyzed.Case presentationA 44-year-old Chinese woman with ...
Xugang Zhang +7 more
doaj +1 more source
Targeted genomic rearrangements using CRISPR/Cas technology [PDF]
Genomic rearrangements are frequently observed in cancer cells but have been difficult to generate in a highly specific manner for functional analysis.
Choi, Peter S., Meyerson, Matthew
core +1 more source
VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research [PDF]
Accurate variant calling in next generation sequencing (NGS) is critical to understand cancer genomes better. Here we present VarDict, a novel and versatile variant caller for both DNA- and RNA-sequencing data.
Ahdesmaki, Miika +9 more
core +2 more sources

